C1ORF198 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.672600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.449400E-01
Normal-vs-Stage2
9.401800E-01
Normal-vs-Stage3
9.352800E-01
Normal-vs-Stage4
3.214400E-01
Stage1-vs-Stage2
7.551000E-01
Stage1-vs-Stage3
7.583800E-01
Stage1-vs-Stage4
1.872960E-01
Stage2-vs-Stage3
7.958600E-01
Stage2-vs-Stage4
1.151240E-01
Stage3-vs-Stage4
4.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.775000E-01
Normal-vs-AfricanAmerican
4.262600E-01
Normal-vs-Asian
6.276400E-01
Caucasian-vs-AfricanAmerican
7.257800E-02
Caucasian-vs-Asian
8.360300E-02
AfricanAmerican-vs-Asian
7.181800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.964000E-01
Normal-vs-Female
8.405400E-01
Male-vs-Female
8.691000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.809000E-01
Normal-vs-Age(41-60Yrs)
9.522200E-01
Normal-vs-Age(61-80Yrs)
8.393800E-01
Normal-vs-Age(81-100Yrs)
6.669000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.712400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.080000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.347000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.392200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.863000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.677800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.011400E-01
Normal-vs-Daily Drinker
4.014600E-01
Normal-vs-Weekly Drinker
6.477000E-01
Normal-vs-Occasional Drinker
6.478200E-01
Normal-vs-Social Drinker
9.379400E-01
Non Drinker-vs-Daily Drinker
1.186210E-01
Non Drinker-vs-Weekly Drinker
2.088600E-01
Non Drinker-vs-Occasional Drinker
5.160000E-01
Non Drinker-vs-Social Drinker
9.375000E-01
Daily Drinker-vs-Weekly Drinker
2.164200E-02
Daily Drinker-vs-Occasional Drinker
3.883600E-01
Daily Drinker-vs-Social Drinker
1.635820E-01
Weekly Drinker-vs-Occasional Drinker
1.000840E-01
Weekly Drinker-vs-Social Drinker
3.216600E-01
Occasional Drinker-vs-Social Drinker
5.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.007800E-01
Normal-vs-Grade 2
7.599800E-03
Normal-vs-Grade 3
4.755600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.445600E-02
Grade 1-vs-Grade 3
1.592000E-01
Grade 1-vs-Grade 4
2.007800E-01
Grade 2-vs-Grade 3
3.515400E-01
Grade 2-vs-Grade 4
7.599800E-03
Grade 3-vs-Grade 4
4.755600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.327400E-01
Normal-vs-NonDiabetic
9.145200E-01
Diabetic-vs-NonDiabetic
3.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.424000E-01
Normal-vs-NoPancreatitis
8.690400E-01
Pancreatitis-vs-NoPancreatitis
9.422800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.252400E-01
Normal-vs-N1
8.756000E-01
N0-vs-N1
8.704000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.077600E-01
Normal-vs-TP53-NonMutant
6.567200E-01
TP53-Mutant-vs-TP53-NonMutant
2.077800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
